• 1
    Helmick CG, Lawrence RC, Pollard RA, Lloyd E, Heyse SP 1995 Arthritis and other rheumatic conditions: Who is affected now, who will be affected later? Natl Arthr Data Workgroup Arthritis Care Res 8: 203211.
  • 2
    National Osteoporosis Foundation 2004 Osteoporosis: Fast facts. Available online at Accessed August 8, 2004.
  • 3
    Frost HM 1973 Bone Modeling and Skeletal Modeling Errors. Orthopedic Lectures, vol. 1. C.C. Thomas, Springfield, IL, USA, p. 214.
  • 4
    Frost HM 1987 The mechanostat: A proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. Bone Miner 2: 7385.
  • 5
    Zippel H 1992 Julius Wolff and the law of bone remodelling. In: RegelingG (ed.) Wolff's Law and Connective Tissue Regulation. Walter de Gruyter, New York, NY, USA, pp. 112.
  • 6
    Turner CH 1999 Toward a mathematical description of bone biology: The principle of cellular accommodation. Calcif Tissue Int 65: 466471.
  • 7
    van der Linden JC, Birkenhager-Frenkel DH, Verhaar JA, Weinans H 2001 Trabecular bone's mechanical properties are affected by its non-uniform mineral distribution. J Biomech 34: 15731580.
  • 8
    Hernandez CJ, Beaupre GS, Carter DR 2003 A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos Int 14: 843847.
  • 9
    Huiskes R, Ruimerman R, van Lenthe GH, Janssen JD 2000 Effects of mechanical forces on maintenance and adaptation of form in trabecular bone. Nature 405: 704706.
  • 10
    Lemaire V, Tobin FL, Greller LD, Cho CR, Suva LJ 2004 Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. J Theor Biol 229: 293309.
  • 11
    Paglia F, Dionisi S, De Geronimo S, Rosso R, Romagnoli E, Raejntroph N, Ragno A, Celi M, Pepe J, D'Erasmo E, Minisola S, Raejentroph N 2001 Biomarkers of bone turnover after a short period of steroid therapy in elderly men. Clin Chem 47: 13141316.
  • 12
    Saag KG 2004 Prevention of glucocorticoid-induced osteoporosis. South Med J 97: 555558.
  • 13
    USA FDA 2004 Innovation/Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products. Available online at Accessed October 19, 2004.